Results 1 to 10 of about 1,223,155 (304)

Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo

open access: yesCells
Synthetic mRNA produced by in vitro transcription (ivt mRNA) is the active pharmaceutical ingredient of approved anti-COVID-19 vaccines and of many drugs under development.
Shahab Mamaghani   +10 more
doaj   +1 more source

Modern vaccines and coronavirus infections

open access: yesИсследования и практика в медицине, 2020
Vaccines represent an outstanding success story in modern medicine and are responsible for a huge reduction in morbidity and mortality worldwide. It is clear that improvements are necessary to enable the development of successful vaccines against some ...
Yu. A. Belikova   +2 more
doaj   +1 more source

Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice

open access: yesMemorias do Instituto Oswaldo Cruz, 1994
Multiple antigen peptide systems (MAPs) allow the incorporation of various epitopes in to a single synthetic peptide immunogen. We have characterized the immune response of BALB/c mice to a series of MAPs assembled with different B and T cell epitopes ...
Myriam A. Herrera   +4 more
doaj   +1 more source

Synthetic biology-inspired development of live attenuated influenza vaccines

open access: yesnpj Vaccines
Live attenuated influenza vaccines (LAIVs) provide robust, cross-protective immunity but have traditionally been developed empirically and are associated with safety concerns.
Qisi Zhang   +14 more
doaj   +1 more source

Redesigning Protein Function: Towards Synthetic Vaccines and MHC Mimetics

open access: yesCHIMIA, 1996
Template Assembled Synthetic Proteins (TASP) approach has been applied to mimic 3D-conformations of the hen egg white lysozyme antigen (HEL) and the major histocompatibility complex (MHC) and some of their biological properties.
Gabriele Tuchscherer
doaj   +2 more sources

Research progress on emulsion vaccine adjuvants

open access: yesHeliyon
Vaccination is the most cost-effective method for preventing various infectious diseases. Compared with conventional vaccines, new-generation vaccines, especially recombinant protein or synthetic peptide vaccines, are safer but less immunogenic than ...
Zhuanqing Huang   +5 more
doaj   +1 more source

Towards the preparation of synthetic outer membrane vesicle models with micromolar affinity to wheat germ agglutinin using a dialkyl thioglycoside

open access: yesBeilstein Journal of Organic Chemistry, 2019
A series of alkyl thioglycosides and alkyl thiodiglycosides bearing glucose and N-acetylglucosamine residues were prepared by thiol–ene coupling in moderate to good yields (40–85%).
Dimitri Fayolle   +5 more
doaj   +1 more source

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells

open access: yesOncoImmunology, 2019
There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T cell responses.
Catherine Rabu   +12 more
doaj   +1 more source

Immunogenicity and Protective Effects of an Ag85B Tuberculosis Subunit Vaccine Formulated with Synthetic TLR4 Agonists in BCG-Boosted Mice

open access: yesVaccines
Background/Objectives: Tuberculosis (TB) remains a major global health challenge, and the Bacillus Calmette–Guérin (BCG) vaccine has limited efficacy against adult pulmonary disease. Protein subunit vaccines are a promising alternative but require strong
Soo-Min Kim   +7 more
doaj   +1 more source

Design and Immune Profile of Multi-Epitope Synthetic Antigen Vaccine Against SARS-CoV-2: An In Silico and In Vivo Approach

open access: yesVaccines
Background: The rapid advancement of the pandemic caused by SARS-CoV-2 and its variants reinforced the importance of developing easy-to-edit vaccines with fast production, such as multi-epitope DNA vaccines.
Maria da Conceição Viana Invenção   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy